Patient that comes in for Acute Kidney Injury - Nursing Case Study

Pathophysiology

• Primary mechanism: Acute kidney injury (AKI) often results from decreased blood flow to the kidneys, leading to inadequate perfusion and oxygen delivery. This can occur due to hypovolemia, heart failure, or systemic vasodilation, causing ischemic damage to renal tissues.

• Secondary mechanism: Direct nephrotoxic injury can also precipitate AKI, where substances like certain medications, contrast agents, or toxins damage renal tubular cells, impairing their function and leading to cell necrosis.

• Key complication: The accumulation of waste products, such as urea and creatinine, and electrolyte imbalances, like hyperkalemia, can result from impaired kidney function, necessitating prompt intervention to prevent further systemic complications.

Patient Profile

Demographics:

64-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Chronic Kidney Disease Stage 3

• Current medications: Lisinopril, Metformin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Decreased urine output and fatigue

• Key symptoms: Nausea, mild swelling in lower extremities, confusion, shortness of breath

• Vital signs: Blood pressure 158/94 mmHg, heart rate 112 bpm, respiratory rate 24 breaths per minute, temperature 99.1°F, oxygen saturation 91% on room air

Section 1

As the healthcare team conducts an initial assessment, the patient's presentation of acute kidney injury becomes increasingly concerning. Upon examination, the patient exhibits notable signs of fluid overload, evidenced by worsening peripheral edema and jugular venous distension. Auscultation reveals bilateral crackles in the lung bases, suggesting pulmonary congestion. The patient's confusion has also intensified, with disorientation to time and place, which may indicate uremic encephalopathy. Initial lab results show significantly elevated serum creatinine at 3.9 mg/dL, a marked increase from the patient's baseline of 1.8 mg/dL, and blood urea nitrogen (BUN) at 45 mg/dL. Additionally, serum potassium levels are critically high at 6.2 mEq/L, posing a risk for cardiac complications. These findings correlate with the patient's reduced urine output and the observed systemic symptoms.

In response to these findings, the clinical team prioritizes stabilizing the patient's electrolyte imbalances and addressing fluid overload. Continuous cardiac monitoring is initiated in light of the hyperkalemia. An ECG shows peaked T waves, consistent with high potassium levels, necessitating immediate intervention. The patient receives intravenous calcium gluconate to stabilize cardiac membranes, along with insulin and glucose to facilitate intracellular potassium shift. Concurrently, a loop diuretic is administered to promote diuresis and reduce fluid volume, alongside supplemental oxygen to address hypoxia. Despite these interventions, the patient's oxygen saturation remains marginally improved at 93% with supplemental oxygen, indicating that further investigation into potential underlying causes, such as heart failure or worsening renal function, is necessary.

As the team monitors the patient's response, there is a need to reassess treatment efficacy and explore additional diagnostic avenues. A decision is made to obtain a chest X-ray to evaluate the extent of pulmonary congestion and an echocardiogram to assess cardiac function, given the patient's history of hypertension and potential for heart failure. These steps are crucial in refining the management plan and preventing the progression of complications associated with acute kidney injury and its systemic effects. Through careful observation and timely interventions, the team aims to stabilize the patient's condition and mitigate the risks of further renal and cardiovascular compromise.

Section 2

As the healthcare team continues to monitor the patient, new diagnostic results from the chest X-ray and echocardiogram provide further insight into the patient's condition. The chest X-ray reveals significant pulmonary edema, consistent with fluid overload, and mild cardiomegaly, suggesting the possibility of underlying heart failure. The echocardiogram shows a reduced ejection fraction of 40%, indicating systolic dysfunction and corroborating the suspicion of heart failure exacerbating the acute kidney injury. These findings emphasize the need for a more aggressive management strategy to address both the cardiac and renal components of the patient's condition.

In response to these new diagnostic results, the clinical team adjusts the treatment plan. An increase in the dosage of the loop diuretic is considered to enhance fluid removal and alleviate pulmonary congestion. Additionally, the team contemplates initiating an ACE inhibitor to manage the patient's hypertension and improve cardiac output, while carefully monitoring renal function to avoid exacerbating the kidney injury. Close observation of the patient's electrolyte levels is maintained to prevent further complications from electrolyte imbalances, particularly concerning potassium. These tailored interventions underscore the importance of integrating cardiac and renal management to stabilize the patient effectively.

Despite these adjustments, the patient's clinical status remains tenuous. The patient exhibits persistent confusion, likely related to ongoing uremic encephalopathy, and continues to experience intermittent episodes of shortness of breath. Vital signs show a heart rate of 98 beats per minute, blood pressure fluctuating around 150/95 mmHg, and respiratory rate of 24 breaths per minute, with oxygen saturation stable at 94% on high-flow oxygen. The team recognizes the potential need for renal replacement therapy if the patient's renal function does not improve with medical management. This possibility is carefully considered as the team prepares for the next steps in the patient's care, ensuring readiness to escalate interventions if necessary to prevent further deterioration.

Section 3

As the healthcare team continues to manage the patient's condition, a new complication arises, prompting a reassessment of the current treatment strategy. The patient develops hyperkalemia, with serum potassium levels rising to 6.2 mmol/L, likely exacerbated by both the renal impairment and the administration of ACE inhibitors. This elevated potassium level presents a significant risk for cardiac arrhythmias, necessitating immediate intervention to stabilize the patient's electrolyte balance. The team promptly administers calcium gluconate to protect the heart, insulin and glucose to facilitate intracellular potassium shift, and considers the use of sodium polystyrene sulfonate to enhance potassium elimination.

Concurrently, the patient's respiratory status deteriorates further, with increased work of breathing and a respiratory rate now consistently at 28 breaths per minute. Despite high-flow oxygen, the oxygen saturation has decreased to 90%, suggesting worsening pulmonary edema or potential progression to acute respiratory distress syndrome (ARDS). The team deliberates the need for non-invasive ventilation to improve oxygenation and reduce respiratory effort, while simultaneously considering the potential benefits of renal replacement therapy to address both fluid overload and persistent electrolyte imbalances.

These developments necessitate renewed clinical reasoning to prioritize interventions that address the most immediate threats to the patient's stability. The team must balance aggressive management of cardiac and renal complications while preparing for possible escalation of care, including the initiation of dialysis. This situation underscores the interconnected nature of the patient's conditions and the importance of a dynamic, multidisciplinary approach to adapt to evolving clinical challenges.

Section 4

As the healthcare team continues to monitor the patient, a change in status becomes evident. Despite the initial interventions to address hyperkalemia, the patient's serum potassium level remains elevated at 5.8 mmol/L. The persistent hyperkalemia, coupled with the ongoing renal impairment, raises concerns about the effectiveness of current treatment strategies. The team decides to initiate renal replacement therapy to more effectively manage the electrolyte imbalances and fluid overload. This decision is also influenced by the patient's worsening respiratory status, which suggests that aggressive fluid management is crucial to prevent further deterioration.

In parallel, the patient's respiratory condition continues to decline. Although non-invasive ventilation was considered, the patient's increasing dyspnea and signs of respiratory distress indicate the need for more definitive intervention. The respiratory rate has escalated to 32 breaths per minute with accessory muscle use, and oxygen saturation has dropped to 88% despite high-flow oxygen therapy. A chest X-ray reveals bilateral infiltrates consistent with pulmonary edema, and there is growing concern about the development of acute respiratory distress syndrome (ARDS). The team deliberates the potential need for intubation and mechanical ventilation to stabilize the patient's respiratory function while renal replacement therapy is underway.

These developments prompt the healthcare team to reassess their approach, balancing the acute need to address both cardiac and respiratory complications. The patient's condition highlights the complexity of managing intertwined systems, necessitating a coordinated, multidisciplinary response. Close monitoring of the patient's hemodynamic status, electrolyte levels, and respiratory function will be vital as the team prepares for potential escalation of care, emphasizing the importance of adaptability and vigilant clinical reasoning in the face of evolving challenges.

Section 5

As the healthcare team implements renal replacement therapy, they observe the patient's response closely, noting any changes in clinical status. Initial post-therapy lab results show a slight improvement in the serum potassium level, now at 5.4 mmol/L. However, the patient's renal function remains critically impaired with a rising creatinine level of 3.2 mg/dL and an estimated glomerular filtration rate (eGFR) of 20 mL/min, indicating persistent acute kidney injury. Additionally, the patient develops new-onset oliguria, with urine output dropping to 15 mL/hour over the last four hours, suggesting worsening renal perfusion and function.

Simultaneously, the patient's respiratory status continues to present challenges. Despite the initiation of mechanical ventilation, the patient's oxygenation remains suboptimal, with an arterial blood gas analysis indicating a PaO2 of 60 mmHg and a PaCO2 of 55 mmHg, resulting in a respiratory acidosis with a pH of 7.31. The bilateral pulmonary infiltrates on chest X-ray are now more pronounced, and crackles are auscultated throughout the lung fields, confirming the progression to acute respiratory distress syndrome (ARDS). This respiratory compromise necessitates the adjustment of ventilator settings, including increasing the positive end-expiratory pressure (PEEP) to improve alveolar recruitment and oxygenation.

These developments underscore the complexity of the patient's condition, necessitating a reevaluation of the treatment plan. The team considers the need for diuretic therapy to manage fluid overload while balancing the risk of exacerbating renal dysfunction. Additionally, continuous monitoring of hemodynamic parameters and laboratory values is crucial to guide further interventions. The interplay of impaired renal and respiratory systems requires an integrated approach, with the multidisciplinary team remaining vigilant to promptly address any further complications that may arise. The patient's evolving condition highlights the importance of dynamic clinical reasoning and adaptability in acute care settings.